TP53 and breast carcinoma: We extended this analysis by including additional p53-deficient cell lines (H358 and H1299, both non-small cell lung cancer cell lines; p53 analysis in Figure S1C) as well as cells possessing wild-type p53 protein (HCT116 p53WT and breast cancer MCF7 cell line).